Press releases

Month Year

Email alerts

Your search returned 130 results

Oct 31, 2016

First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes

Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing

DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...
Sep 30, 2016

FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls

DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...
Aug 25, 2016

Medtronic Reports First Quarter Financial Results

Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week

DUBLIN - August 25, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2017, which ended July 29, 2016. The company reported first quarter...
Jul 28, 2016

HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue

- Global revenue increased approximately 25% from first quarter of 2016

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Jun 27, 2016

Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International

Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector

DUBLIN and FRAMINGHAM, Mass. - June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of...

Show per page